How academia can increase the value of research articles

With all the money invested in obtaining research funding, universities should invest more in the end product of that research, namely the publications. That is the argument made by the authors of a recent paper on improving the medical research literature.

The authors identified 3 targets that could help universities improve the publications from their researchers: introducing publications officers into the academic environment, training researchers how to be authors, and training researchers how to be peer reviewers.
Continue reading How academia can increase the value of research articles

How drug and device companies should distribute scientific literature about unapproved uses

The US Food and Drug Administration (FDA) provides guidance to pharmaceutical and medical device manufacturers about distributing information on unapproved uses of their products. In 2009, the FDA released what is commonly referred to as “Good Reprint Practices.“* The FDA recognized that off-label or unapproved uses could be important to the standard of clinical care and to health care providers knowledge.

The guidelines were meant to outline how this information should be disseminated, through what types of publications, and how the information should be qualified. The ultimate goal was to allow companies to share scientific research about unapproved uses without promoting these uses. Continue reading How drug and device companies should distribute scientific literature about unapproved uses